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Domestic Animals–Case Report
Metastasizing Esthesioneuroblastoma in a Dog
K. Siudak1, M. Klingler2, M. J. Schmidt2, and C. Herden1
Abstract
A 7-year-old Afghan hound presented with a history of disorientation, loss of vision, and seizures. Magnetic resonance imaging
helped identify a mass at the level of the main olfactory bulb that compressed and displaced adjacent tissues in the cribriform plate
into the nasal cavity and nasopharynx. Bony structures were osteolytic. After removing almost 80% of the mass, the tumor
recurred a few months later. Due to severe respiratory distress and subsequent to an ultrasound diagnosis of a liver tumor, the
dog was euthanized. In addition to the nasal mass, a single nodule in the liver and multiple nodules in the lung were present. All
masses had similar cell morphology and were diagnosed as metastasizing esthesioneuroblastoma. The neoplastic cells expressed
neuron-specific enolase and chromogranin A, and a few cells within the nasal mass were positive for cytokeratin. This is the first
description of a canine esthesioneuroblastoma with distant metastases.
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Olfactory neuroblastoma or esthesioneuroblastoma is a rare
malignant neoplasm arising in the nasal cavity of humans and
domestic animals.8,13 Cases in cats, dogs, horses, a heifer, and a
monkey have been described.1,3,4,7,10,12,18
The neoplastic cells presumably originate from neuroepithe-
lial precursor cells and are typically located in close proximity
to the cribriform plate.2 Invasive growth leads to osteolysis and
deformation of the ethmoturbinates. Metastases to regional
lymph nodes, choroid, and retina have been described.7,10,16
Metastases to any other peripheral organs are lacking.
This report presents the first description of distant metas-
tases (lung, liver) of a canine esthesioneuroblastoma.
Case History
A 7-year-old male Afghan hound race dog was presented to
the Klinik fu¨r Kleintiere, Chirurgie, Justus Liebig Universita¨t
(JLU) of Gießen due to disorientation, loss of vision, listless-
ness, and seizures. Neurologic examination revealed bilateral
ventral strabismus, loss of the menace reflex on the right side,
pain on palpation of the lumbar region, and a bilateral hyper-
metric knee-jerk reaction.
Magnetic resonance imaging (MRI) of the head revealed
an ovoid, moderately heterogeneous, nasal mass at the level
of the right side of the cribriform plate, accompanied by
osteolysis. The tumor extended through the nasal cavity into
the caudal nasopharynx. The adjacent tissue, especially parts
of the main olfactory bulb and the lobus frontalis, was com-
pressed; both cerebral hemispheres and the cerebellum were
displaced caudally. Approximately 80% of the tumor mass
was removed surgically.
The remaining neoplastic tissue was treated with irradiation
(a total of 40 Gy). None of the preexisting clinical signs
recurred after treatment. Almost 8 months later, the patient
re-presented with severe respiratory distress due to continuous
regrowth of the nasal mass. Ultrasound examination revealed a
nonhomogeneous mass in the liver. Due to a poor prognosis,
the dog was euthanized and necropsied.
Materials and Methods
Tissue specimens were fixed in 10% nonbuffered formalin for
2 to 3 days, embedded in paraffin wax, sectioned at approxi-
mately 5 mm, and stained with hematoxylin and eosin.
Immunohistochemistry for vimentin, synaptophysin, S100
protein (S100), glial fibrillary acidic protein (GFAP), neuro-
filament protein, cytokeratin, neuron-specific enolase (NSE),
neuronal nuclear antigen (NeuN), and chromogranin A was
performed (Suppl. Table S1). Positive controls for each mar-
ker were run simultaneously.
The slides were deparaffinized in xylene substitute (Roti-
Histol; Carl Roth GmbH & Co KG, Karlsruhe, Germany) and
rehydrated via a descending alcohol series. Endogenous
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peroxidase activity was inhibited by incubation in methanol
with freshly added 0.5% hydrogen peroxide for 30 minutes
at room temperature. Further details regarding the pretreatments
are listed in Supplemental Table S1. The sections were incubated
overnight with the primary antibodies at 4C. For the detection
of vimentin, synaptophysin, neurofilament protein, cytokeratin,
NSE, and NeuN, a biotinylated secondary horse anti–mouse
antibody (Vector Laboratories, Burlingame, CA) was used
according to the ABC staining method (1:100, 30 minutes at
room temperature). Simultaneously, a secondary swine anti–
rabbit IgG H þ L antibody (DAKO, Hamburg, Germany),
diluted in Tris-buffered saline (TBS) containing 20% swine
serum (1:100), was applied for S100, chromogranin A, and
GFAP (30 minutes at room temperature) according to the per-
oxidase anti–peroxidase (PAP) staining method. Detection of
antibody binding was achieved by a peroxidase-based detection
system (Vectastain ABC kit standard; Vector Laboratories).
Visualization of antibody binding was achieved by adding
3,30-diaminobenzidine (DAB; Sigma-Aldrich GmbH, Tauf-
kirchen, Germany) as chromogen for 10 minutes. Counterstain-
ing was carried out with Papanicolaou solution (1:20; Merck,
Darmstadt, Germany) for 30 seconds. After dehydration, all
slides were mounted with a xylene-based solution.
Pathologic Findings
The mass within the nasal cavity was oval, 5  3  3 cm, and
compressed the intracranial region of the main olfactory bulb
(Figs. 1, 2). The surface was irregular and covered by a thin
layer of brown mucus.
The liver had a single, beige mass 15 cm in diameter in the
right lobe with central dimpling (Fig. 3). Multiple, small
nodules were randomly distributed throughout the lung. They
measured up to 1  0.5  0.5 cm, and their cut surfaces were
white and firm. Both apical lung lobes had few, small, firm,
dark red lesions.
The frontal cortex had marked astrogliosis and macrophage
infiltration within the meninges at the region of the main olfac-
tory bulb. Samples of the nasal mass harvested at surgery and
necropsy, the mass within the liver, and the small nodules
within the lung were composed of uniform neoplastic cells with
similar morphologic features. The masses were moderately
cellular and infiltrative. Nests of tumor cells were unencapsu-
lated but well demarcated by moderate amounts of fibrovas-
cular stroma. The nests were composed of small cuboidal to
columnar cells mixed with some spindloid cells (Figs. 4, 5).
Occasionally, they had a glandular or palisading pattern. Cells
had small to moderate amounts of eosinophilic, homogeneous
cytoplasm with indistinct cell borders. Nuclei were round,
hyperchromatic, and often basally located in the columnar
cells. Nucleoli were inconspicuous. Mitotic figures were rare,
less than one per 400 field. Pseudorosettes (Homer-Wright
rosettes) were frequently observed in all neoplastic tissues
(Fig. 5). Extensive areas of necrosis were randomly located
throughout the neoplasms. A mild infiltration of inflammatory
cells, mainly lymphocytes, and a few foci of hemorrhage and
numerous siderophages were present in outer regions of the
masses, as well as small areas of dystrophic calcification.
Tumor cells expressed NSE and chromogranin A in the nasal
cavity, liver, and lung (Figs. 6, 7). Neoplastic cells did not
express vimentin, synaptophysin, neurofilament, NeuN, S100,
or GFAP. Single neoplastic cells of the nasal cavity expressed
cytokeratin, whereas no cytokeratin expression was present in
any metastatic masses (Suppl. Table S2). Apical lung lobes had
mild suppurative bronchopneumonia.
Discussion
Malignant tumors of the nasal cavity in dogs are rare and are
mostly carcinomas followed by different types of sarcomas.8
Esthesioneuroblastomas occur rarely and share histologic
features with neuroendocrine carcinomas.17 Discrimination
between tumor types can be problematic. Nasal neuroendocrine
carcinomas likely arise from neuroendocrine cells dispersed
within the entire sinonasal area; therefore, restriction of tumor
to the cribriform plate as present in our case suggests a diagnosis
of esthesioneuroblastoma.11,17 Invasive tumor growth, in combi-
nation with destruction of adjacent bony structures, is most com-
monly present in esthesioneuroblastomas.13Both neuroendocrine
tumors and esthesioneuroblastomas may have rosettes and pali-
sading cells. The expression of neuroendocrine markers such as
NSE or chromogranin is indicative but not absolutely diagnostic
for esthesioneuroblastomas.17 Calcification and necrosis are
infrequently present in canine esthesioneuroblastomas.2 In com-
bination, these features are of limited diagnostic value. Unfortu-
nately, precise immunohistologic differentiation is hampered
by the inconsistent expression pattern of neuroglial markers in
both tumor types.17 Esthesioneuroblastomas can express NSE,
S-100 protein, GFAP, and, less frequently, chromogranin, class
III b-tubulin, microtubule-associated protein 2 (MAP-2), synap-
tophysin, neurofilament protein, NeuN, and cytokeratin.2,17 In
comparison, neuroendocrine carcinomas in dogs commonly have
Figure 1. Esthesioneuroblastoma, nasal cavity; Afghan hound. Neo-
plastic mass in the nasal cavity at the level of the cribriform plate
(arrow) with invasion into the bulbus olfactorius. Magnetic resonance
imaging.
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positive immunostaining for cytokeratin AE1/AE3, synaptophy-
sin, NSE, chromogranin A, and S100 as well as vasoactive intest-
inal peptide (VIP).15 The positive reactions for NSE and
chromogranin A and the lack of a positive staining for synapto-
physin support a diagnosis of esthesioneuroblastoma in our case,
although staining for NeuN, neurofilament, S100, andGFAPwas
not present. Whether this expression pattern, with loss of neuro-
glial markers, is associated with more aggressive behavior and
distantmetastases remains unknown.Amore intense immunohis-
tochemical staining for cytokeratin is expected in nasal neuroen-
docrine carcinomas. In the present case, only single cells of the
nasal tumor and no cells within the metastases expressed
Figure 2. Esthesioneuroblastoma, nasal cavity; dog. An irregular neoplasm obstructs the meatus. Figures 3–4. Esthesioneuroblastoma, liver;
dog. Figure 3. A tumor in the right lobe of the liver measures 15 cm in diameter. Figure 4. Tumor nests, separated by a moderate amount of
fibrovascular stroma, surround a vessel. Note the unaffected liver parenchyma (asterisk) with hyperemia. Figures 5–7. Esthesioneuroblastoma,
nasal cavity; 7-year-old Afghan hound. Figure 5. Formation of a true rosette (Flexner-Wintersteiner rosette), where cells are arranged around
a central lumen. Hematoxylin and eosin. Figure 6. Immunohistochemistry (IHC) shows expression of neuron-specific enolase in tumor cells.
Figure 7. IHC for chromogranin A shows positive labeling of tumor cells.
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cytokeratin. Ultrastructurally, esthesioneuroblastoma should dis-
play neural processes containingmicrotubules.17 However, ultra-
structural examination was not available for the case presented
here.Amore detailed histologic grading scheme for esthesioneur-
oblastomas is available in human medicine.11 Four grades are
defined around features such as the presence of rosettes, number
of mitoses, evidence of necrosis and calcification, and nuclear
pleomorphism. Grade III and IV tumors seem to correlate with
lower survival times in people.2 Applying this grading scheme
to our single canine case, the low mitotic index and foci of dys-
trophic calcification fulfill grade II criteria. The prominent necro-
sis inmany locations of the nasal mass is consistent with grade III
and IV tumors. Therefore, this canine esthesioneuroblastoma is
classified between grades II and III. It is, however, questionable
whether this grading system is relevant to esthesioneuroblasto-
mas in animals. In humans, distant metastases of esthesioneuro-
blastomas occur occasionally in locations including the cervical
lymph nodes, lung, and bone; atypically in the neck; and rarely
in the chestwall.5,6,13 In people, ‘‘dropmetastases’’ are intradural,
extramedullary, spinal metastases distal to the primary tumor.
They arise subsequent to exfoliation of neoplastic cells into the
cerebrospinal fluid of the subarachnoid space.14 In animals, esthe-
sioneuroblastomas have been reported in the choroid and retina in
a horse and in the regional lymph nodes in dogs.7,10,17
In the present case, metastases may have occurred due to a
longer survival time than in previously reported cases and
perhaps due to a more malignant phenotype.12 Also, surgical
manipulation could have caused vascular invasion and conse-
quently formation of metastases. Survival is estimated as
almost 1 year after radiation therapy.12 Median survival time
of dogs with tumors in the nasal cavity is approximately 16.5
months.9 The lack of distant metastases in animals may be
due to euthanasia after initial diagnosis. Furthermore, severe
clinical signs and the expense of radiation treatment may
shorten survival times. The presence of distant metastases
in this case indicates a potentially aggressive behavior of this
tumor type in animals. Future study is indicated to more pre-
cisely address the biological properties and prognoses of
esthesioneuroblastomas.
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